Epigenetic alteration by DNA-demethylating treatment restores apoptotic response to glucocorticoids in dexamethasone-resistant human malignant lymphoid cells

Table 1 Cell cycle analysis, Figures1, 2 and 3D

Cell type	Treatment	% G1	% G2	% S	% A	% Deb
Figure 1 D, CEM clones
C7- 14	Control	57.5	6.125	36.27	00.035	00.845
C7- 14	Dex	75.87	29.45	21.19	34.18	25.92
C1- 6	Control	50.99	4.18	44.83	00.075	1.715
C1- 6	Dex	64.24	7.31	28.44	00.02	25.43
C1- 15	Control	51.695	8.705	39.6	00.005	00.88
C1- 15	Dex	52.815	9.355	37,8	2.07	2.055
IV- B9	Control	58.415	5.975	35.6	00.09	1.405
IV- B9	Dex	58.615	5.435	35.95	58.855	18.75
Figure 2 D, MOLT- 4 (uncloned)	Control	58.82	8.57	32.62	00.03	5.83
	Dex	62.85	8.14	29.0	00.12	2.94
	AZA	58.02	10.00	31.8	00.66	21.3
	AZA + Dex	73.64	6.64	19.72	00.00	34.91
Figure 3 D, RPMI (uncloned)	Control	61.71	11.73	26.46	00.00	2.32
	Dex	59.88	9.31	30.81	6.40	2.87
RPMI clone II E6	Control	56.02	11.51	32.47	6.72	11.30
	Dex	51.31	42.6	6.09	1.5	46.58

ISSN: 1475-2867